- 全部删除
您的购物车当前为空
AG-13958 (AG-013958) 是 VEGFR 酪氨酸激酶抑制剂,可用于年龄相关性黄斑变性 (AMD) 的脉络膜新生血管形成的研究。

AG-13958 (AG-013958) 是 VEGFR 酪氨酸激酶抑制剂,可用于年龄相关性黄斑变性 (AMD) 的脉络膜新生血管形成的研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 993 | In stock | |
| 5 mg | ¥ 2,480 | In stock | |
| 10 mg | ¥ 3,650 | In stock | |
| 25 mg | ¥ 5,720 | In stock | |
| 50 mg | ¥ 7,690 | In stock | |
| 100 mg | ¥ 9,870 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,550 | In stock |
AG-13958 相关产品
| 产品描述 | AG-13958 (AG-013958) (AG-013958), a potent VEGFR tyrosine kinase inhibitor, for the treatment of age-related macular degeneration. |
| 别名 | N-[2-氟-5-[[3-[(1E)-2-(2-吡啶基)乙烯基]-1H-吲唑-6-基]氨基]苯基]-1,3-二甲基-1H-吡唑-5-甲酰胺, AG-013958 |
| 分子量 | 467.5 |
| 分子式 | C26H22FN7O |
| CAS No. | 319460-94-1 |
| Smiles | Cc1cnn(C)c1C(=O)Nc1cc(Nc2ccc3c(\C=C\c4ccccn4)n[nH]c3c2)ccc1F |
| 密度 | 1.35 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 5 mg/mL (10.7 mM), Sonication is recommended. | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容